Patents by Inventor Wolfdieter Springer

Wolfdieter Springer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small Molecule Activators of Parkin Enzyme Function
    Publication number: 20230128765
    Abstract: The present disclosure relates to compounds for activating the enzymatic activity of an E3 ubiquitin ligase and methods for treating a disease or disorder in a subject with diminished E3 ubiquitin ligase enzymatic activity. In some embodiments, the present disclosure provides a compound of Formula I or a compound of Formula II. or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: April 27, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Wolfdieter Springer, Fabienne C. Fiesel, Thomas R. Caulfield
  • Small molecule activators of Parkin enzyme function
    Patent number: 11401255
    Abstract: The present disclosure relates to compounds for activating the enzymatic activity of an E3 ubiquitin ligase and methods for treating a disease or disorder in a subject with diminished E3 ubiquitin ligase enzymatic activity. In some embodiments, the present disclosure provides a compound of Formula (I) or a compound of Formula (II) or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: August 2, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Wolfdieter Springer, Fabienne C. Fiesel, Thomas R. Caulfield
  • Small Molecule Activators of Parkin Enzyme Function
    Publication number: 20190169158
    Abstract: The present disclosure relates to compounds for activating the enzymatic activity of an E3 ubiquitin ligase and methods for treating a disease or disorder in a subject with diminished E3 ubiquitin ligase enzymatic activity. In some embodiments, the present disclosure provides a compound of Formula (I) or a compound of Formula (II) or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 28, 2017
    Publication date: June 6, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Wolfdieter Springer, Fabienne C. Fiesel, Thomas R. Caulfield